Trial Profile
Phase I Study of Pre-operative Continuous 5-FU, and Sorafenib With External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Apr 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Fluorouracil
- Indications Rectal cancer
- Focus Adverse reactions
- 08 Apr 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 29 Feb 2016 Planned End Date changed from 1 Apr 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 22 Apr 2015 Planned End Date changed from 1 Jun 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov